Impact of expiry of global patents 'less than feared' | Medical Informer

Home

Home » Medicine & Supplements » Lexapro » Impact of expiry of global patents 'less than feared'

Impact of expiry of global patents 'less than feared'

Posted on 04 December 2012. Tags: &#39less, expiry, feared&#39, Global, impact, patents, than

Impact of expiry of global patents 'less than feared'
In terms of blockbuster drugs thought to be produced here, Davy cites the following, with US patent expirations in brackets: Lipitor (expired); Enbrel (Jan 2016); Actos (Aug 2012); Singulair (Aug 2012); Zyprexa (expired); Lexapro (expired); Diovan …

Full News here – Read more on Irish Examiner

Leave a Reply Cancel reply

Latest
Popular
Comments
Tags
Subscribe

Use Avocado To Cure Erectile Dysfunction May 25, 2013
Bausch & Lomb Unit to Pay $33.5 Million on Conspiracy, Kickback Charges May 25, 2013
Comedian Tom Stade on close to the bone jokes and Frankie Boyle May 25, 2013
One in five of people with asthma are sensitive to aspirin May 25, 2013
Barnstable District Court May 25, 2013

lasik November 2, 2011
CT scan (3/13) – Medical Informer Video November 12, 2011
Cosmetic Surgery Documentary – Ethnic Nose Job – Plastic Surgeon Beverly Hills – Medical Informer Video November 23, 2011
Aspirin Toner – Medical Informer Video November 29, 2011
Animation about diabetes and the body. – Medical Informer Video December 5, 2011